A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. (ZHANG YUWEI / XINHUA)

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

ALSO READ: Trials for 2 Sinopharm COVID-19 vaccines progress